Zhengjin Cao

934 citations
8 papers · 755 indexed · h-index 8
Topics
Mitochondrial Function and Pathology (5 papers)Metabolism and Genetic Disorders (4 papers)Genetic Neurodegenerative Diseases (3 papers)
Partner nations
United States

In The Last Decade

Zhengjin Cao

8 papers receiving 739 citations

Peers

Zhengjin Cao
Comparison fields: 5 of 77
  • Molecular Biology 598
  • Physiology 295
  • Clinical Biochemistry 141
  • Aging 92
  • Cellular and Molecular Neuroscience 86
Replace Entela Bua with:
Entela Bua United States
Daniel Pulliam United States
Johanna H.K. Kauppila Germany
Ulf Brunk Sweden
Michele D. Allen United States
Timo E.S. Kauppila Sweden
Sylviane Lagarrigue Switzerland
Nelson H. Knudsen United States
Grigor Varuzhanyan United States
Svetlana Altshuler-Keylin United States
Zhengjin Cao relative to Entela Bua United States Entela Bua's profile →
Citations per field
00.5×1.5×
Entela Bua · 1×
Citations per year

Countries citing papers authored by Zhengjin Cao

Since Specialization
Citations

This map shows the geographic impact of Zhengjin Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengjin Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengjin Cao more than expected).

Fields of papers citing papers by Zhengjin Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengjin Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengjin Cao. The network helps show where Zhengjin Cao may publish in the future.

Co-authorship network of co-authors of Zhengjin Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengjin Cao. A scholar is included among the top collaborators of Zhengjin Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengjin Cao. Zhengjin Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 75
2 12
3 93
4 70
5 44
6 142
7 297
8 22

About Zhengjin Cao

Zhengjin Cao is a scholar working on Clinical Biochemistry, Cellular and Molecular Neuroscience and Health, Toxicology and Mutagenesis, having authored 8 papers that have together received 755 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (4 papers) and Genetic Neurodegenerative Diseases (3 papers). The work is most often cited by research in Aging (92 citations), Clinical Biochemistry (141 citations) and Physiology (295 citations). Zhengjin Cao has collaborated with scholars based in United States. Frequent co-authors include Judd M. Aiken, Jonathan Wanagat, Debbie McKenzie, Susan H. McKiernan, Entela Bua, Marisol E. Lopez, Damian J. Lee, Nolan G. Gokey, Jeong W. Pak and Richard Weindruch. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026